Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

P

PVLA

Palvella Therapeutics Inc

140.24

Jul 29 • 10:49 AM ET -2.60 (-1.82%)

Healthcare Biotechnology USA Mid NASD

Peers: KYMR MANE ORKA RYTM KRYS NUVL BMRN INCY AXSM NBIX

| Held by: VTI XBI IWM VXF IWO VTWO VHT VFMO LFSC SBIO

Scroll to Statements

Index	RUT
Market Cap	2.01B
Enterprise Value	1.77B
Income	-49.30M
Sales	0.00M
Book/sh	16.23
Cash/sh	18.26
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	29
IPO	Jan 02, 2015

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	8.64
P/C	7.68
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	28.88
Current Ratio	28.88
Debt/Eq	0.09
LT Debt/Eq	0.09
Option/Short	Yes / Yes

EPS (ttm)	-4.17
EPS next Y	-6.54
EPS next Q	-1.18
EPS this Y	-49.38%
EPS next Y	-18.06%
EPS next 5Y	3.05%
EPS past 3/5Y	53.08% 41.62%
Sales past 3/5Y	- -
EPS Y/Y TTM	66.94%
Sales Y/Y TTM	-
EPS Q/Q	-62.12%
Sales Q/Q	-
Earnings	Aug 04 BMO
EPS/Sales Surpr.	-28.34% -

Insider Own	29.40%
Insider Trans	-0.45%
Inst Own	83.28%
Inst Trans	33.35%
ROA	-28.73%
ROE	-34.25%
ROIC	-19.52%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-2.65%
SMA50	9.50%
SMA200	28.93%
Trades

Shs Outstand	14.31M
Shs Float	10.13M
Short Float	21.49%
Short Ratio	8.20
Short Interest	2.18M
52W High	161.38 -13.10%
52W Low	34.57 305.67%
Volatility	4.96% 8.24%
ATR (14)	10.25
RSI (14)	50.85
Beta	-0.16
Rel Volume	0.42
Avg Volume	265.46K
Volume	27,135

Perf Week	-1.36%
Perf Month	-9.43%
Perf Quarter	11.34%
Perf Half Y	67.01%
Perf YTD	33.98%
Perf Year	260.70%
Perf 3Y	705.24%
Perf 5Y	-48.74%
Perf 10Y	-0.40%
Recom	1.00
Target Price	229.00
Prev Close	142.84
Price	140.24
Change	-1.82%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)